Teva Wins FDA Tentative Approval for Generic Breast Cancer Drug

Teva Pharmaceutical Industries has reported that the FDA has granted tentative approval for the company’s abbreviated new drug application to market its generic version of Novartis’s breast cancer treatment Femara tablets, 2.5mg.
TradingMarkets